Physician profile
Shane J Ashford
NPI 1518144534
$18,198.54
in general payments reported to CMS, 2019-2025
72 companies · $3,604 in 2025
The $3,604 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,238 · 2020: $1,682 · 2021: $2,011 · 2022: $2,241 · 2023: $3,214 · 2024: $3,208 · 2025: $3,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $7.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,017.32 |
| Education | $7.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,457.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,737.83 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,534.49 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $1,166.37 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $1,033.99 | 2019-2025 | Evenity, Repatha, Prolia |
| Lilly USA, LLC | $953.83 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $749.90 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $708.54 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $592.26 | 2019-2025 | Spravato, Xarelto, Invega Sustenna |
| Bayer Healthcare Pharmaceuticals INC. | $577.24 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $497.33 | 2020-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $466.74 | 2019-2025 | |
| Astellas Pharma US INC | $360.44 | 2020-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $318.16 | 2019-2025 | Capvaxive, Gardasil 9, Belsomra |
| Takeda Pharmaceuticals U.S.A., INC. | $311.34 | 2019-2024 | Trintellix |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $289.77 | 2020-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $278.57 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $274.82 | 2022-2025 | |
| Exact Sciences Corporation | $272.31 | 2023-2024 | Cologuard Collection Kit |
| Antares Pharma, INC. | $229.94 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Dexcom, INC. | $227.25 | 2021-2025 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $184.13 | 2023-2025 | Auvelity, Symbravo |
| Lundbeck LLC | $179.43 | 2024-2025 | Rexulti, Vyepti |
| Corcept Therapeutics | $168.92 | 2023-2025 | Korlym |
| Abbott Laboratories | $165.52 | 2021-2024 | Freestyle Libre 3 |
| Sunovion Pharmaceuticals INC. | $160.48 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $155.85 | 2024-2025 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $148.60 | 2025 | Caplyta |
| Sumitomo Pharma America, INC. | $130.94 | 2023-2025 | Gemtesa |
| Sanofi Pasteur INC. | $127.68 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $107.40 | 2019-2025 | Austedo Xr, Austedo Xr |
| Shield Therapeutics INC | $102.60 | 2024-2025 | |
| Nevro Corp. | $93.08 | 2022-2024 | Senza |
| Radius Health, INC. | $92.12 | 2019-2025 | Tymlos |
| Allergan, INC. | $80.48 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $63.45 | 2022 | |
| Tris Pharma INC | $58.64 | 2024-2025 | Dyanavel Xr |
| Esperion Therapeutics, INC. | $58.30 | 2021-2025 | Nexletol |
| Nalpropion Pharmaceuticals LLC | $56.29 | 2019 | |
| Ibsa Pharma INC. | $55.12 | 2020-2025 | Tirosint, Flector, Licart |
| Pacira Therapeutics, INC. | $54.76 | 2020 | |
| Currax Pharmaceuticals LLC | $52.82 | 2019-2024 | Contrave |
| Alnylam Pharmaceuticals INC. | $52.61 | 2021-2024 | Oxlumo, Givlaari |
| Ironwood Pharmaceuticals, INC | $52.00 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $51.97 | 2024 | |
| Valeritas, INC. | $51.48 | 2019 | |
| Eisai INC. | $50.85 | 2020-2021 | |
| Dynavax Technologies Corporation | $47.20 | 2023-2025 | Heplisav-B |
| Pacira Pharmaceuticals Incorporated | $43.42 | 2023-2025 | Zilretta, Iovera, Exparel |
| Biohaven Pharmaceuticals, INC. | $41.32 | 2020-2021 | |
| Seqirus USA INC | $37.61 | 2024 | Flucelvax, Fluad |
| Vivus LLC | $35.90 | 2019-2024 | Qsymia |
| Arbor Pharmaceuticals, INC. | $33.92 | 2019-2021 | |
| Biogen, INC. | $33.35 | 2021 | |
| Nestle Healthcare Nutrition INC. | $32.91 | 2023 | |
| Inari Medical, INC. | $25.76 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mylan Specialty L.P. | $25.44 | 2024 | Yupelri |
| Shire North American Group INC | $24.90 | 2019 | |
| Inspire Medical Systems, INC. | $24.82 | 2024 | Inspire |
| Amneal Pharmaceuticals LLC | $22.42 | 2025 | Crexont |
| Recordati_rare_diseases_inc. | $19.99 | 2025 | Isturisa |
| Acella Pharmaceuticals, LLC | $18.32 | 2025 | NP Thyroid 60 |
| Medtronic, INC. | $16.81 | 2021 | |
| Phadia US INC. | $15.57 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.68 | 2019 | |
| Genentech USA, INC. | $14.07 | 2020 | |
| Supernus Pharmaceuticals, INC. | $13.85 | 2022 | |
| Azurity Pharmaceuticals, INC. | $13.51 | 2025 | Edarbyclor |
| Avvisto Therapeutics, LLC | $13.10 | 2024 | Cycloset |
| Optinose US, INC. | $12.43 | 2021 | |
| Medtronic USA, INC. | $11.52 | 2020 | |
| Upsher-Smith Laboratories LLC | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Ashford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.